3

PRIMARY DOCUMENT

Company: Coeptis Therapeutics Holdings, Inc.
Filed: November 9, 2020
Period of Report: October 30, 2020
Accession Number: 0001076809-20-000217

View Document ↗ View on SEC.gov ↗